Lite Strategy Inc
LITS
NASDAQ
Biotechnology
$0.89
USD
-0.01 (-1.01%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $30.37M
Volume 80.8K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2026 | Q2 2026 | Q3 2026 |
|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 3.1 | 3.3 | 2.7 |
Other Operating Expenses | 0.6 | 0.0 | 18.8 |
Total Operating Expenses | 3.7 | 3.4 | 21.6 |
Operating Income | -3.7 | -3.4 | -21.6 |
EBITDA | -3.1 | -3.4 | -21.6 |
Other Income / Expense | 0.0 | -27.5 | -2.1 |
Total Other Income / Expense | 0.1 | -27.4 | -2.1 |
Income Before Income Taxes | -3.6 | -30.8 | -23.7 |
Income Taxes | 0.0 | 0.0 | 0.0 |
Net Income | -3.6 | -30.8 | -23.7 |
Consolidated Net Income / Loss | -3.6 | -30.8 | -23.7 |
Net Income Attributable to Common Shareholders | -3.6 | -30.8 | -23.7 |
Basic EPS | -$0.12 | -$0.82 | -$0.66 |
Diluted EPS | -$0.12 | -$0.82 | -$0.66 |
Basic Shares Outstanding | 29.5M | 37.4M | 35.7M |
Diluted Shares Outstanding | 29.5M | 37.4M | 35.7M |